• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Noncompliance in organ transplant recipients: a literature review.

作者信息

Laederach-Hofmann K, Bunzel B

机构信息

Internal Medicine and Cardiology FMH, Unit for Psychosomatic and Psychosocial Medicine, Inselspital, University of Berne, Berne, Switzerland.

出版信息

Gen Hosp Psychiatry. 2000 Nov-Dec;22(6):412-24. doi: 10.1016/s0163-8343(00)00098-0.

DOI:10.1016/s0163-8343(00)00098-0
PMID:11072057
Abstract

The consequences of failing to comply to doctor's instructions can be damaging and devastating for the individual patient and their family. Noncompliance also leads to waste, as it reduces the potential benefits of therapy, and to the extra cost of treating avoidable consequent morbidity. Life-long immunosuppression is a prerequisite for good graft function, and noncompliance is often associated with late acute rejection episodes, graft loss, and death. It might be assumed that transplant patients constitute a highly motivated group, and that compliance would be high. Unfortunately, this is not the case: overall noncompliance rates vary from 20 to 50%. This overview includes literature on heart, liver, and kidney transplants in adult and pediatric transplant patients. Compliance behavior after transplantation, noncompliance and its relationship to organ loss and death, retransplantation outcome after graft loss due to noncompliance, and reasons for postoperative noncompliance will be addressed.

摘要

相似文献

1
Noncompliance in organ transplant recipients: a literature review.
Gen Hosp Psychiatry. 2000 Nov-Dec;22(6):412-24. doi: 10.1016/s0163-8343(00)00098-0.
2
[Noncompliance in organ transplantation: a review].[器官移植中的不依从性:综述]
Wien Klin Wochenschr. 2000 May 19;112(10):423-40.
3
Solid organ transplantation: are there predictors for posttransplant noncompliance? A literature overview.实体器官移植:是否存在移植后不依从性的预测因素?文献综述。
Transplantation. 2000 Sep 15;70(5):711-6. doi: 10.1097/00007890-200009150-00001.
4
Is noncompliance among adolescent renal transplant recipients inevitable?青少年肾移植受者的不依从性是否不可避免?
Pediatrics. 2005 Apr;115(4):969-73. doi: 10.1542/peds.2004-0211.
5
Late acute rejection and subclinical noncompliance with cyclosporine therapy in heart transplant recipients.心脏移植受者的晚期急性排斥反应及环孢素治疗的亚临床不依从性
J Heart Lung Transplant. 1998 Sep;17(9):854-63.
6
Noncompliance with immunosuppressive medications in pediatric and adolescent patients receiving solid-organ transplants.接受实体器官移植的儿科和青少年患者对免疫抑制药物的不依从性。
Transplantation. 2004 Mar 15;77(5):778-82. doi: 10.1097/01.tp.0000110410.11524.7b.
7
Clinical risk associated with appointment noncompliance in heart transplant recipients.心脏移植受者预约不依从相关的临床风险。
Prog Transplant. 2000 Sep;10(3):162-8. doi: 10.1177/152692480001000306.
8
Temporary discontinuation of immunosuppressive treatment and renal graft rejection. Experience of a center in Venezuela.免疫抑制治疗的临时中断与肾移植排斥反应。委内瑞拉某中心的经验
Rev Panam Salud Publica. 2006 Nov;20(5):338-40. doi: 10.1590/s1020-49892006001000007.
9
Growing pains: non-adherence with the immunosuppressive regimen in adolescent transplant recipients.成长的烦恼:青少年移植受者对免疫抑制方案的不依从性
Pediatr Transplant. 2005 Jun;9(3):381-90. doi: 10.1111/j.1399-3046.2005.00356.x.
10
Incidence, determinants, and consequences of subclinical noncompliance with immunosuppressive therapy in renal transplant recipients.肾移植受者亚临床免疫抑制治疗不依从的发生率、决定因素及后果
Transplantation. 1995 Feb 15;59(3):340-7.

引用本文的文献

1
Barriers to Immunosuppressant Medication Adherence in Thoracic Transplant Recipients: Initial Findings.胸科移植受者免疫抑制剂药物依从性的障碍:初步研究结果。
Int J Environ Res Public Health. 2025 Jul 8;22(7):1090. doi: 10.3390/ijerph22071090.
2
Association between the Stanford Integrated Psychosocial Assessment for Transplant and 1-year medication nonadherence after living kidney transplantation.肾移植术后斯坦福移植综合心理社会评估与1年药物治疗不依从性之间的关联。
PCN Rep. 2025 Jun 9;4(2):e70128. doi: 10.1002/pcn5.70128. eCollection 2025 Jun.
3
Developing biomedical engineering technologies for reproductive medicine.
开发用于生殖医学的生物医学工程技术。
Smart Med. 2022 Dec 27;1(1):e20220006. doi: 10.1002/SMMD.20220006. eCollection 2022 Dec.
4
Challenges with non-descriptive compliance labeling of end-stage renal disease patients in accessibility for renal transplantation.终末期肾病患者肾移植可及性方面非描述性依从性标签的挑战。
World J Nephrol. 2024 Mar 25;13(1):88967. doi: 10.5527/wjn.v13.i1.88967.
5
Nonadherence to Immunosuppressants Among Transplant Recipients: Emotional Intelligence as a Predictive Factor During COVID-19 Pandemic.器官移植受者中免疫抑制剂治疗的不依从性:新冠疫情期间情商作为预测因素
Patient Prefer Adherence. 2023 Nov 27;17:3083-3092. doi: 10.2147/PPA.S426358. eCollection 2023.
6
Prevalence and Patient-Level Correlates of Intentional Non-Adherence to Immunosuppressive Medication After Heart-Transplantation-Findings From the International BRIGHT Study.心脏移植后免疫抑制药物非依从性的发生率及其与患者相关的因素——来自国际 BRIGHT 研究的结果。
Transpl Int. 2023 Jul 10;36:11308. doi: 10.3389/ti.2023.11308. eCollection 2023.
7
Characterization of the stanford integrated psychosocial assessment for transplant for heart, liver, and kidney transplant candidates in Japan.日本心脏、肝脏和肾脏移植候选人的斯坦福移植综合心理社会评估特征
Biopsychosoc Med. 2023 Jul 17;17(1):24. doi: 10.1186/s13030-023-00281-6.
8
Immunosuppressant Adherence Factors Differentiating Compliant and Non-Compliant Kidney Transplant Recipients.区分依从性和非依从性肾移植受者的免疫抑制剂依从性因素
J Clin Med. 2023 Jun 16;12(12):4081. doi: 10.3390/jcm12124081.
9
A novel inducible haematopoietic cell-depleting mouse model for chimeric complementation of blood cells.一种新型诱导性造血细胞耗竭小鼠模型,用于嵌合血细胞的互补。
Cell Prolif. 2023 May;56(5):e13472. doi: 10.1111/cpr.13472. Epub 2023 May 17.
10
Medication Adherence among Allogeneic Haematopoietic Stem Cell Transplant Recipients: A Systematic Review.异基因造血干细胞移植受者的药物依从性:一项系统综述
Cancers (Basel). 2023 Apr 25;15(9):2452. doi: 10.3390/cancers15092452.